<Page>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
-------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
February 19, 2003
-----------------
CUBIST PHARMACEUTICALS, INC.
----------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 0-21379 22-3192085
- --------------------------------------------------------------------------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
65 Hayden Avenue, Lexington, Massachusetts 02421
------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (781) 860-8660
---------------
<Page>
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) EXHIBITS.
99.1 Press Release dated February 19, 2003
99.2 Transcript of February 19, 2003 conference call
ITEM 9. REGULATION FD DISCLOSURE.
On February 19, 2003, the Registrant issued a press release reporting
its fourth quarter and full year results for 2002. The press release has been
filed as an exhibit to this Report on Form 8-K, attached hereto as Exhibit 99.1.
On February 19, 2003, the Registrant conducted a telephone conference.
The conference call transcript has been filed as an exhibit to this Report on
Form 8-K, attached hereto as Exhibit 99.2.
The attached press release and transcript are not "filed" pursuant to
the Securities Exchange Act and are not incorporated by reference into any
Securities Act registration statements. Additionally, the submission of this
report on Form 8-K is not an admission as to the materiality of any information
in this report that is required to be disclosed solely by Regulation FD.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CUBIST PHARMACEUTICALS, INC.
By: /s/ David W.J. McGirr
------------------------------------------
David W.J. McGirr
Senior Vice President and Chief Financial
Officer
Dated: February 19, 2003